| Closed |
S0941 |
Phase II Cholangiocarcinoma with Sorafenib + Erlotinib |
4/15/2010 |
9/15/2011 |
73% |
|
Published
|
| Closed |
S1314 |
Phase II COXEN Trial for Localized Bladder Cancer |
7/9/2014 |
12/1/2017 |
100% |
|
|
| Closed |
SWOG-9350 |
Phase II Disseminated Malignant Melanoma |
8/1/1994 |
11/13/1996 |
39% |
|
Published
|
| Closed |
S0333 |
Phase II Double Induction for Newly Diagnosed Non-L3 ALL |
4/15/2005 |
|
100% |
|
|
| Closed |
S1001 |
Phase II Early Stage DLBCL |
7/18/2011 |
6/1/2016 |
100% |
|
|
| Closed |
S0125 |
Phase II Elderly AML in First Complete Remission |
4/1/2003 |
6/1/2005 |
10% |
|
|
| Closed |
SWOG-7916 |
Phase II Evaluation of Gallium Nitrate in Metastatic Urological Malignancies: Testicular, Bladder, Prostate and Kidney |
7/20/1979 |
1/19/1984 |
|
|
Published
|
| Closed |
SWOG-8304 |
Phase II Evaluation of L-Alanosine in Metastatic Carcinoma of the Breast |
5/27/1983 |
5/4/1984 |
|
|
Published
|
| Closed |
SWOG-7918 |
Phase II Evaluation of m-AMSA in Lymphoma - Hodgkin's and Non-Hodgkin's |
7/12/1979 |
4/14/1981 |
|
|
|
| Closed |
SWOG-8519 |
Phase II Evaluation of Methyl-Glyoxal Bis- Guanylhydrazone (MGBG) in Patients With Advanced Bladder Cancer |
1/1/1986 |
5/15/1989 |
|
|
Published
|
| Closed |
SWOG-7921 |
Phase II Evaluation of MGBG in Metastatic Carcinoma of the Breast |
7/12/1979 |
10/22/1980 |
|
|
|
| Closed |
S0805 |
Phase II HyperCVAD + Dasatinib with or without Allo SCT for Ph+ ALL |
9/1/2009 |
|
100% |
|
Published
|
| Closed |
S0919 |
Phase II Idarubicin/AraC + Pravastatin for Relapsed AML |
8/15/2009 |
9/15/2017 |
100% |
|
|
| Closed |
S0115 |
Phase II Melphalan + Auto PBSC Trans. for High Risk MM / Amyloidosis - BMT Study |
1/1/2004 |
10/15/2010 |
95% |
|
Published
|
| Closed |
S1108 |
Phase II MLN8237 in Peripheral T-Cell NHL |
10/28/2011 |
6/6/2013 |
100% |
|
Published
|
| Closed |
S0117 |
Phase II Mylotarg™ for Relapsed AML |
4/1/2003 |
10/15/2005 |
60% |
|
|
| Closed |
S0703 |
Phase II Older Previously Untreated Non-M3 AML |
12/1/2008 |
|
93% |
|
Published
|
| Closed |
S0636 |
Phase II OSI-774/Bevacizumab in Neversmokers with St. IIIB and IV Primary NSCLC Adenocarcinoma |
7/15/2007 |
9/1/2010 |
100% |
|
|
| Closed |
S0635 |
Phase II OSI-774/Bevacizumab in St. IIIB and IV BAC and AdenoBAC |
7/15/2007 |
8/15/2011 |
95% |
|
|
| Closed |
SWOG-8364 |
Phase II Pilot Study of Immediate Post-Operative Adjuvant Chemotherapy in Patients with Operable Breast Cancer |
5/27/1983 |
9/27/1985 |
|
|
|
